Resumen
Hospitalized patients with coronavirus disease 2019 (COVID-19) experiencing respiratory symptoms have different complications (inflammatory, co-infection, and thrombotic) that are identifiable by analytics patterns. Personalized treatment decisions decreased early mortality (odds ratio [OR]. 144; 95% confidence interval [CI]. 03-.686; P = .015). Increasing age (OR 1.06; P = .038) and therapeutic effort limitation (OR 9.684; P < .001) were associated with higher mortality.
Idioma original | Inglés estadounidense |
---|---|
Páginas (desde-hasta) | 127-132 |
- | 6 |
Publicación | Clinical Infectious Diseases |
Volumen | 74 |
N.º | 1 |
DOI | |
Estado | Indizado - 1 ene. 2022 |
Nota bibliográfica
Publisher Copyright:© 2020 The Author(s). Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.